These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8620524)

  • 21. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
    Irvine K; Schlom J
    Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Ross AH; Iliopoulos D; Koprowski H
    Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
    Steinitz M; Tamir S; Frödin JE; Lefvert AK; Mellstedt H
    J Immunol; 1988 Nov; 141(10):3516-22. PubMed ID: 2846688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.
    Maruyama H; Benden A; Li W; Zaloudik J; Koido T; Taupin JL; Acres B; Somasundaram R; Prewett M; Herlyn D
    Int J Cancer; 1996 Feb; 65(4):547-53. PubMed ID: 8621241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy and immunotherapy of colorectal cancer.
    Masucci G; Ragnhammar P; Frödin JE; Hjelm AL; Wersäll P; Fagerberg J; Osterborg A; Mellstedt H
    Med Oncol Tumor Pharmacother; 1991; 8(3):207-20. PubMed ID: 1803182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of HAMA in patients treated with mouse monoclonal antibodies.
    Frödin JE; Lefvert AK; Mellstedt H
    Cell Biophys; 1992; 21(1-3):153-65. PubMed ID: 1285327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
    Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
    Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-idiotype immunization of cancer patients: modulation of the immune response.
    Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-EpCAM monoclonal antibody (MAb17-1A) based treatment combined with alpha-interferon, 5-fluorouracil and granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
    Liljefors M; Ragnhammar P; Nilsson B; Ullenhag G; Mellstedt H; Frödin JE
    Int J Oncol; 2004 Sep; 25(3):703-11. PubMed ID: 15289873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.
    Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R
    Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
    Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody.
    Vázquez AM; Pérez A; Hernández AM; Macías A; Alfonso M; Bombino G; Pérez R
    Hybridoma; 1998 Dec; 17(6):527-34. PubMed ID: 9890708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-idiotypic antibodies bear the internal image of a human tumor antigen.
    Herlyn D; Ross AH; Koprowski H
    Science; 1986 Apr; 232(4746):100-2. PubMed ID: 3952496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.
    Durrant LG; Denton GW; Jacobs E; Mee M; Moss R; Austin EB; Baldwin RW; Hardcastle JD; Robins RA
    Int J Cancer; 1992 Mar; 50(5):811-6. PubMed ID: 1544714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.
    Clark JI; Alpaugh RK; von Mehren M; Schultz J; Gralow JR; Cheever MA; Ring DB; Weiner LM
    Cancer Immunol Immunother; 1997 Jul; 44(5):265-72. PubMed ID: 9247561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
    Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
    In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
    Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
    Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of anti-idiotypic and anti-anti-idiotypic monoclonal antibodies in the same fusion. Support of Jerne's Network Theory.
    Hébert J; Bernier D; Boutin Y; Jobin M; Mourad W
    J Immunol; 1990 Jun; 144(11):4256-61. PubMed ID: 2341720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.